ALLMedicine™ Pediatric Medulloblastoma Center
Research & Reviews 93 results
https://doi.org/10.1148/radiol.212137
Radiology Zhang M, Wong SW et. al.
Apr 20th, 2022 - Background Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk stratification, which may aid therapeutic decision making, family counseling, and selection of patient groups suitable for targeted genetic analysis. Purp...
https://doi.org/10.1007/s00381-022-05507-6 10.1200/JCO.2016.67.2428 10.1200/JCO.2017.72.7842 10.1200/JCO.2010.28.1675 10.1093/neuonc/nos267 10.1200/JCO.2010.30.2810 10.1080/02688690903121807 10.1158/1078-0432.CCR-07-4159 10.1158/1078-0432.CCR-07-2072 10.1007/s00401-016-1569-6 10.1200/JCO.2009.27.4324 10.1038/nrneurol.2012.78 10.1007/s00401-012-0958-8 10.3174/ajnr.A3990 10.3174/ajnr.A5899 10.1007/s00330-017-5180-6 10.1093/annonc/mdz001 10.1016/S1470-2045(18)30413-3 10.1158/1078-0432.CCR-16-0702 10.1093/neuonc/now050 10.1016/j.neuroimage.2006.01.015 10.1158/1078-0432.CCR-16-2910 10.1158/0008-5472.CAN-17-0339 10.1016/j.crad.2004.07.008 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3 10.1158/1078-0432.CCR-04-0713 10.1002/sim.6370 10.1158/1078-0432.CCR-13-2320 10.1016/j.jocn.2011.04.029 10.1007/s00234-010-0829-8 10.1007/s11060-015-1779-0
Child's Nervous System : ChNS : Official Journal of the I... Liu ZM, Zhang H et. al.
Apr 9th, 2022 - To develop and validate a radiomics signature for progression-free survival (PFS) and radiotherapeutic benefits in pediatric medulloblastoma. We retrospectively enrolled 253 consecutive children with medulloblastoma from two hospitals. A total of ...
https://doi.org/10.1016/j.ymthe.2022.03.012
Molecular Therapy : the Journal of the American Society O... Kaushik I, Srivastava SK
Mar 26th, 2022 - The Sonic hedgehog-activated subgroup of medulloblastoma (SHH-MB) is one of the most common malignant pediatric brain tumors. Recent clinical studies and genomic databases indicate that GABAA receptor holds significant clinical relevance as a ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938370
Journal of Neuro-oncology; Obrecht D, Mynarek M et. al.
Feb 23rd, 2022 - To evaluate the clinical impact of isolated spread of medulloblastoma cells into cerebrospinal fluid without additional macroscopic metastases (M1-only). The HIT-MED database was searched for pediatric patients with M1-only medulloblastoma diagnos...
https://doi.org/10.1002/pbc.29569
Pediatric Blood & Cancer; Huang HY, Yu CH et. al.
Feb 5th, 2022 - Medulloblastoma (MB) is commonly classified into four molecular groups, that is, WNT, SHH, group 3, and group 4, for prognostic and therapeutic purposes. Here we applied immunohistochemistry (IHC) and RNA sequencing (RNA-seq) for the molecular cla...
Clinicaltrials.gov 2 results
https://clinicaltrials.gov/ct2/show/NCT02747576
Oct 15th, 2021 - Comprehensive social-cognitive and behavioral data will be collected and structural and functional brain imaging will be completed in an attempt to determine if disruptions to brain integrity and function caused by prior treatment of medulloblasto...
https://clinicaltrials.gov/ct2/show/NCT01697514
Aug 27th, 2013 - The purpose of this study is to find a recommended dose level of LY2940680 that can be safely given to children with medulloblastoma or rhabdomyosarcoma that has returned or doesn't respond to initial treatment. The study will also explore the cha...
News 2 results
https://www.medpagetoday.com/radiology/therapeuticradiology/84097
Dec 23rd, 2019 - Proton therapy for pediatric brain tumors led to significantly better longitudinal intelligence outcomes as compared with conventional radiation therapy, results of a matched-cohort study showed. With a median follow-up of 4 to 5 years, children w...
https://www.staging.medscape.com/viewarticle/858312
Feb 4th, 2016 - For children with medulloblastoma, proton-beam radiotherapy should be considered an "attractive alternative" to conventional radiotherapy, the authors of a new study conclude. Proton-beam therapy "is effective in decreasing many of the late side e...
